Missed our live discussion on invasive haemodynamic assessment? ๐ซ
The replay is now available.
Explore right heart catheterisation, invasive bedside assessment and exercise haemodynamics in heart failure and structural heart disease.
๐ฅ Watch now: https://t.co/JLTsb9nR7R
๐ฅ Meet the team behind the Pre-Course on Cardiogenic Shock!
Developed jointly by iHF and the MCS Focus Group, the Programme brings together six specialists across anaesthesiology, cardiac surgery and cardiology.
๐ Discover the Programme for 21 November: https://t.co/vjbpUjIDwe
@AlexMebazaa@EmanueleBarba13@SabineBleiziff2@FlavioRibichini
#IHF #PCRLV
๐ฅ @AlexMebazaa invites you to join the Pre-Course!
Explore practical education in heart failure and cardiogenic shock, and discover what the programme has to offer.
๐ Learn more: https://t.co/imGhu7A6Xe
๐๏ธ 21 November, London
#IHF#HeartFailure
โStarting in 5 minutes!
Join the iHF faculty live to explore invasive haemodynamic assessment, from right heart catheterisation and key measurements to exercise haemodynamics.
โถ๏ธ Join now: https://t.co/JLTsb9nR7R
๐ป LIVE in 6 hours!
How can invasive haemodynamic assessment improve precision in clinical management, and what are the key considerations for right heart catheterisation?
Join todayโs free iHF webinar at 5:30pm (UTC+2).
๐ Register now for free: https://t.co/JLTsb9ooXp
Missed our live discussion on #HFpEF and coronary microvascular dysfunction? ๐ซ
The replay is now available.
Explore diagnosis, patient selection and evidence informing tailored treatment strategies through case-based discussion.
๐ฅ Watch now: https://t.co/HRvcjteuD6
๐ซ New iHF webinar: Invasive haemodynamic assessment can provide important insights into clinical management.
Explore right heart catheterisation, invasive bedside assessment and exercise haemodynamics during this free live iHF Webinar.
๐ 20 October, 5:30pm (UTC+2)
@Marta33717088@AlexMebazaa
๐ https://t.co/m6JylSn4pR
โ Starting in 5 minutes!
Join the iHF faculty LIVE to explore coronary microvascular dysfunction in #HFpEF, from diagnosis and patient selection to tailored treatment strategies.
โถ๏ธ Join now: https://t.co/WZcVcby82b
๐ป LIVE in 6 hours!
How can coronary microvascular dysfunction be diagnosed in HFpEF, and how can the evidence guide tailored treatment?
Join todayโs free iHF Webinar at 5:30pm (UTC+2).
๐ Register now for free: https://t.co/WZcVcby82b
NEW PRE-COURSE | Cardiogenic shock: "Eyes on the pump" ๐ซ
Join the iHF & PCR MCS Focus Group on 21 November in London, ahead of #PCRLondonValves.
A focused, interactive Programme on MCS decision-making, device selection, complications, escalation & weaning.
Discover more โ https://t.co/XcFervcFUi
@PCRonline@AlexMebazaa@EmanueleBarba13@SabineBleiziff2@FlavioRibichini
#CardiogenicShock #MCS
Recognising coronary microvascular dysfunction in #HFpEF is only the first step.
Explore diagnosis, patient selection and the evidence informing tailored treatment during this free live iHF Webinar.
๐ 29 September, 5:30pm (UTC+2)
๐ https://t.co/WZcVcby82b
TR in heart failure: when to suspect, when to worry, when to act?
Join our webinar with the PCR Tricuspid Focus Group, featuring @MariannaAdamo1, @masitges, @GMCRosano, Marina Urena & Mirjam Wild.
๐ Thursday 3 September | 5:00 PM UTC+2
Register now: https://t.co/ctU2rpUl5h
@pcr_online #Cardiology #HeartFailure #CardioTwitter
Tricuspid Regurgitation in Heart Failure: when to suspect, when to worry, when to act
๐๏ธNext live #PCRWebinar: Thursday 3 September 2026, 5:00pm (UTC+2)!
๐งโโ๏ธ@MariannaAdamo1, @masitges, @GMCRosano, Marina Urena, Mirjam Wild
โ Developed by the #PCRTricuspid Focus Group in collaboration with @iheartfunction
๐Register now: https://t.co/ZqKVKJRbT6
#MedEd #TricuspidRegurgitation #InterventionalCardiology
๐ Tricuspid Regurgitation in Heart Failure: when is it time to act?
When should we suspect TR progression? When should we worry about right-heart deterioration? And when should we refer or intervene?
Join the upcoming live webinar in collaboration with @PCRonline Tricuspid Focus Group for an expert discussion.
๐ Thursday 3 September I 5:00 PM (UTC+2)
๐ป Online I Free
๐ Register now: https://t.co/9wbAFijazH
@MariannaAdamo1 @masitges@GMCRosano
#HeartFailure #TricuspidRegurgitation #Cardiology #CardioEducation #CardioTwitter
๐Do you remember the case of the 39-year-old patient with a late #STEMI complicated by severe biventricular dysfunction and a ventricular septal rupture requiring emergent VA-ECMO and IABP support?
The poll sparked a wide range of opinions - highlighting just how challenging these cases can be.
๐ซNow discover how the Heart Team approached this complex mechanical complication, balancing timing, hemodynamic support, and definitive treatment.
๐Read Part 2: https://t.co/z2y2oIWAa4
#HeartFailure #Cardiology #STEMI #HeartTeam #MedicalEducation #CardioEd
๐ซ New Trial Review: the SUBCUT HF II
Presented at #HFA 2026, the SUBCUT-HF II trial explores whether early discharge with an ambulatory subcutaneous furosemide pump could transform heart failure care.
In this Trial Review, @JanBiegus examines the evidence behind this innovative home-based decongestion strategy.
๐ฅ Watch the full review: https://t.co/L2bE5jimGB
#HeartFailure #Cardiology #ClinicalTrials #CardioEd #Cardiology #CardioEducation
๐ฅMissed our latest iHF webinar? The replay is now available!
Join a multidisciplinary Heart Team discussion on managing patients with HFrEF & chronic coronary syndromes through a real-world case.
๐ https://t.co/tZ6zlu4Bu9
Key topics:
- Patient selection for revascularisation
- PCI vs CABG
- GDMT optimisation after revascularisation
#HeartFailure #Cardiology #HeartTeam #GDMT #CardioEd #CardioTwitter
๐ซCan ARNI therapy improve outcomes in patients with #HFpEF and atrial functional mitral regurgitation?
In this new Journal Club, @Jolie_Bruno_ reviews the PRAISE-MR trial published in Circulation and discusses its potential implications for clinical practice.
Read here:
https://t.co/ebrkN1Gq1f
#HeartFailure #Cardiology #JournalClub #ARNI #HFpEF
๐ซPost-MI ventricular septal rupture: a critical trans-disciplinary case
A 39-year-old patient with no medical history developed a non-restrictive VSD, severe biventricular dysfunction, and cardiogenic shock following a late #STEMI. Despite #PCI and IABP support, he deteriorated and required VA-ECMO.
๐How would you manage this mechanical complication?
๐ Read the case and vote here:
https://t.co/z2y2oIWAa4
@EchoSoliman@BarilliMaria
#HeartFailure #CardiogenicShock #ECMO #VentricularSeptalRupture #CardioEd #CardioTwitter
๐ฅHow can #GDMT and #MCS devices optimize the management of patients with advanced heart failure?
Daniel Burkhoff and @AlexMebazaa share key insights from a #EuroPCR 2026 case-based session covering hemodynamic monitoring, short-term MCS, patient stabilization, GDMT optimization, and advanced therapy pathways.
โถ๏ธ Watch the full replay: https://t.co/f1jNKWcSoS
#AdvancedHeartFailure #HeartFailure #GDMT #Cardiology #CardioEd
โณLive webinar today: one hour that could change your approach to #HFrEF and #CCS!
๐ 19 June 2026 I 5:30pm (UTC+2)
๐Register now: https://t.co/LLDpRZvQZO
Join a discussion with renowned experts to learn more about patient selection for revascularisation, optimal treatment strategies, and the latest developments in GDMT following intervention.
@MartineGilard@drbennisahmed@ARakisheva@SabineBleiziff2@emilianofiorimd@belmontemarta1
#CardioEd #Cardiology #HeartFailure